A

Agilent Technologies Inc (A) Stock Price

Closed
A
$173.78
+$0.78(+0.45%)

Content updated: 2026-11-16 17:01:39

Yesterday's Close
$173.00
Today's Open
$172.84
Today's High
$174.23
Today's Low
$170.45
Volume
1.86M shares
52-Week Range
$108.95-$188.20

As of 2026-11-16 17:01:39, Agilent Technologies Inc (A) was quoted at $173.78, a change of +$0.78 (+0.45%) from the previous close. The day's range was $170.45–$174.23, and the 52-week range was $108.95–$188.20.

Past 1W-4.58%Period Low $168.00Period High $183.00
Past 1M+0.22%Period Low $139.74Period High $188.20
Past 3M+21.93%Period Low $135.48Period High $188.20

About Agilent Technologies Inc (A)

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.
Ticker / Exchanges
A / NYSE
Industry / Sector
Medical - Diagnostics & Research / Healthcare
CEO
Padraig McDonnell
Headquarters
Santa Clara,CA,US
Official Website
https://www.agilent.com
Listing Date
1999-11-18

Recent Company Events

  • 2026-08-26
    Earnings Report · ExpectedOn 2026-08-26, the 2026/Q3 earnings report is expected to be released.

Agilent Technologies Inc (A) Derivatives Trading

CFD

Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.

Agilent Technologies Inc (A) Company Financials

Valuation and Shares

Market Cap
--
P/E Ratio (TTM)
--
P/B Ratio
--
Shares Outstanding
--
Float Shares
--
Dividend Yield (TTM)
--

Latest Reported Financials

2026 Q2 Financials

Report Release Date: 2026-05-27

Operating Revenue (Actual)

$1.83B

Same Period Last Year: +10.01%

Earnings per Share (Actual)

$1.49

Same Period Last Year: +13.74%

Financials · Actuals

Actual Value2022/Annual2023/Annual2024/Annual2025/Annual
Revenue$6.84B$6.83B$6.51B$6.94B
Net Profit$1.25B$1.24B$1.28B$1.30B
Operating Cash Flow$1.31B$1.77B$1.75B$1.55B

Learn

A FAQ

What is the current stock price of Agilent Technologies Inc (A)?

x
As of 2026-11-16 17:01 (UTC+8), the latest available quote for Agilent Technologies Inc (A) is $173.78 USD, with a change of +$0.78 USD (+0.45%) from the previous trading day's close. Current market status: Closed.

Which exchange is A listed on?

x

How has Agilent Technologies Inc stock performed over the past month?

x

What is the market cap of Agilent Technologies Inc?

x

What are Agilent Technologies Inc's latest financial results?

x

What factors may affect the stock price of Agilent Technologies Inc (A)?

x

Other Trading Markets

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.